Author | Lightnews

Lumanity

Lumanity

@lumanity.bsky.social

25 followers 9 following 200 posts

We revolutionize how value is generated, demonstrated, and communicated to unlock the full potential of your brand and your company

Posts Media Videos Starter Packs

Lumanity @lumanity.bsky.social · 35m

Meet our #RWE experts at #ISPOREurope! Discover how leveraging the PHARMO data network can strengthen your #HTA submissions with robust insights. Our team will be on-site and ready to discuss how RWE can add value across the product lifecycle: buff.ly/z6680ml

Lumanity @lumanity.bsky.social · 12h

“You can’t pour from an empty cup.” Tune into our Patient Progress podcast episode, Mental Health in Caregivers. Guest advocates talk about the mental health toll of caregiving — from anxiety, depression, and burnout to moments of post traumatic growth. buff.ly/6Ca9xNq

Lumanity @lumanity.bsky.social · 16h

The US pharma market is evolving fast, are you keeping up? In our recent webinar, Jamie Van Iderstine and Kartin Sood break down the latest on IRA, 340B, Medicaid, and more.

Check out the on-demand recording on our website: buff.ly/NMjTJRI

#MarketAccess #PharmaStrategy

Lumanity @lumanity.bsky.social · 20h

6 months from CE marking to JCA dossier submission? That’s the timeline proposed in the draft Implementing Regulation, and it’s raising alarms. Our article explores why this compressed schedule is misaligned with RWE generation for medical devices: buff.ly/tZL1r9Z #EUHTA

Text: View. Stakeholder Reflections on the Draft EU JCA MD Implementing Regulation

Lumanity @lumanity.bsky.social · 1d

Join us November 19 for a live webinar with leading scientists, biotech innovators, and investment strategists, to explore questions and strategies surrounding IO beyond 2026. Register: buff.ly/xP45NMu #ImmunoOncology #CancerProgress #Biotech #Pharma #DrugDevelopment

Lumanity @lumanity.bsky.social · 1d

If you're in Milwaukee for the 32nd Annual #ISOQOL starting tomorrow, be sure to connect with our staff while on-site. We also have a number of posters at this year's conference. Find out more details here: buff.ly/Ilr5yb6

#ArtificialIntelligence #Conference

Lumanity @lumanity.bsky.social · 1d

We’re counting down to #AMCPNexus 2025!

Our team is looking forward to engaging in meaningful conversations around AI and digital health, real world evidence and biosimilars, and evolving policy and market access strategies. Want to connect? Visit: buff.ly/n72xQHh

Lumanity @lumanity.bsky.social · 1d

Join Laura Watts (Lumanity) and Pascal Hetzscholdt (Wiley) tomorrow at 9:00am ET for a free webinar from ISEH, exploring how to ensure transparency, fairness, and reproducibility in AI-generated outputs and other important questions. Reserve your spot now – registration is free!: buff.ly/T7pqALP

Lumanity @lumanity.bsky.social · 1d

Register for “Charting the Course: Indication Prioritization from Data to Decisive Action”, which will equip you to spot and sidestep the pitfalls that derail indication prioritization among other useful insights: buff.ly/PNHg2q4 #Biopharma #IndicationPrioritization

Lumanity @lumanity.bsky.social · 2d

Tomorrow Ed Saltzman and Jeff Bockman will be speaking at the Global Cancer Research and Innovation Symposium. We look forward to seeing you! See the full agenda: buff.ly/BIlzPED

#GCRIS #biotech #oncology #biopharma

Lumanity @lumanity.bsky.social · 2d

Join us Tomorrow! In this webinar, our experts will explore the hidden risks that derail BD&L success and how a full-spectrum perspective across science, clinical, regulatory, and commercial strategy can change the outcome.

Register here: buff.ly/QhsVGYX

Lumanity @lumanity.bsky.social · 6d

Attending #ESMO25? Catch our staff on-site and check out our poster, Epidemiology and Outcomes in a Linked Cohort of Cancer, Pathology and Electronic Medical Records from the PHARMO Data Network www.esmo.org/meeting-cale...

#Oncology #CancerResearch #Cancer #ESMO #Pharma #Biotech

Lumanity @lumanity.bsky.social · 8d

Strong collaboration between #medical and #commercial teams isn’t just a nice-to-have — it’s a strategic advantage. Listen to the latest #MedicalAffairs Unscripted episode, "Bridging Science and Strategy, The Power of Medical–Commercial Collaboration," lumanity.com/perspectives...

Lumanity @lumanity.bsky.social · 10d

Lumanity will be attending and presenting at the upcoming European Society for Medical Oncology (ESMO) Congress in Berlin from October 17–21. We look forward to engaging with leaders in oncology and exploring the cutting-edge treatments shaping the future of cancer care. buff.ly/OxZsuEH #ESMO2025

Image: Two people celebrating climbing to the top of a mountain. Text: ESMO Congress October 17-21, 2025

Lumanity @lumanity.bsky.social · 12d

Well said!

Reposted by Lumanity

ISEH - International Society for Experimental Hematology @isehsociety.bsky.social · 14d

There are ✌️ weeks left to register for the FREE 22 October webinar on Responsible AI in Research and Publishing featuringLaura Watts, PhD from @lumanity.bsky.social and @p4sc4l.substack.com from Wiley. Register here 👉 iseh.org/Webinars-Eve...

Lumanity @lumanity.bsky.social · 12d

In our new podcast episode, Jenny Payne speaks candidly with Ashlee Cramer and Ceinwen Giles about the realities of caregiving, the sacrifices made, and the moments of post-traumatic growth that can emerge from hardship. Join us in recognizing the voices that too often go unheard: buff.ly/6Ca9xNq

Lumanity @lumanity.bsky.social · 13d

Join us on our upcoming webinar "Embedding Patient-Centricity Across Biopharma: From Asset to Enterprise Transformation," to start building a patient-first future for your business. Register now to secure your spot: buff.ly/vfnPED6

Lumanity @lumanity.bsky.social · 13d

We are honored to be among this year’s #MMMAwards finalists!

As we gear up for the biggest event of the year in medical marketing, we extend our congratulations to all the finalists.

We look forward to celebrating the most inspiring and innovative work in our industry tonight.

Lumanity @lumanity.bsky.social · 13d

In the Netherlands, an estimated 1,500–2,000 individuals are living with #SickleCellDisease (SCD), yet there's limited #RealWorldData on the clinical burden, especially regarding recurrent vaso-occlusive crisis. Learn more at buff.ly/5PNBMxr

#SickleCellAwareness #RWE

Lumanity @lumanity.bsky.social · 14d

Meet the Lumanity Team at AMCP Nexus 2025! We’re looking forward to heading to National Harbor, MD for this year’s #AMCPNexus. Our team of experts will be on-site. Want to connect at the conference? Visit our webpage to schedule a meeting with the team: buff.ly/n72xQHh

Lumanity @lumanity.bsky.social · 14d

Jeff Bockman will join investors, VCs and private equity experts at the Global Cancer Research & Innovation Symposium panel; “Global Trends and Reality Checks on the State of Cancer Research.” Learn more: buff.ly/BIlzPED October 21, 2025 | 8:00am – 8:45am | New York, NY #Oncology #GCRIS

Lumanity @lumanity.bsky.social · 14d

#ICYMI: Psychedelic and psychedelic-inspired treatments are shifting from early promise to scalable reality. Our whitepaper distils the critical decisions for leaders in this space: buff.ly/D4dof51

#MentalHealth #Psychedelics #ClinicalDevelopment

Lumanity @lumanity.bsky.social · 15d

No launch succeeds in isolation. Cross-functional coordination is the driving force behind launch success. Our new guide shows how aligning creative, medical, market access, and client teams can transform your launch trajectory. Learn how to synchronize your teams for launch success: buff.ly/mlKdA07

Lumanity @lumanity.bsky.social · 15d

Ed Saltzman is featuring on an insightful #GCRIS panel; “Biotech Investors: How Do We Navigate Choppy Seas” on October 21 from 8:45-9:30am in New York. This session will tackle funding challenges in cancer research amid political and economic uncertainty. Learn more: buff.ly/BIlzPED #Biotech